Literature DB >> 17484380

Increase of ceramide in the liver and plasma after carbon tetrachloride intoxication in the rat.

Ikuyo Ichi1, Kayoko Nakahara, Kozue Fujii, Chinatsu Iida, Yayoi Miyashita, Shosuke Kojo.   

Abstract

In fulminant hepatic failure, various toxins causing multi-organ failure increase in plasma. As a novel toxin, levels of ceramide, a well-studied lipid mediator of apoptosis, were determined by LC-MS/MS in the liver and plasma of carbon tetrachloride (CCl4)-intoxicated rats. After 6 h of oral administration of CCl4 (4 mL/kg body weight as a 1:1 mixture of CCl4 and mineral oil) to rats, extensive hepatic failure occurred as evidenced by a severe elevation in plasma AST and ALT. The liver concentration of major ceramide components (C16:0, C24:0, C24:1, C18:0, C22:0, and C24:2 in decreasing order), and the sum of these ceramides increased significantly 2 h after CCl4 intoxication compared to that in the control group given mineral oil. The total ceramide concentration in the plasma was also increased to 4.1 times that in the control 24 h after administration of CCl4. In conclusion, the early increase in liver ceramides may contribute to hepatic cell death and the increase in plasma ceramides during fulminant hepatic failure may cause damage in other organs including the brain and kidney.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484380     DOI: 10.3177/jnsv.53.53

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  14 in total

1.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

2.  Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.

Authors:  Takhar Kasumov; Hazel Huang; Yoon-Mi Chung; Renliang Zhang; Arthur J McCullough; John P Kirwan
Journal:  Anal Biochem       Date:  2010-02-21       Impact factor: 3.365

3.  Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.

Authors:  Jonathan Y Xia; William L Holland; Christine M Kusminski; Kai Sun; Ankit X Sharma; Mackenzie J Pearson; Angelika J Sifuentes; Jeffrey G McDonald; Ruth Gordillo; Philipp E Scherer
Journal:  Cell Metab       Date:  2015-07-16       Impact factor: 27.287

Review 4.  The adipokine/ceramide axis: key aspects of insulin sensitization.

Authors:  Jonathan Y Xia; Thomas S Morley; Philipp E Scherer
Journal:  Biochimie       Date:  2013-08-20       Impact factor: 4.079

5.  Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla.

Authors:  Shu-Zhong Chen; Jing Yuan; Min Deng; Juan Wei; Jinyuan Zhou; Yì-Xiáng J Wáng
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

6.  Zonation of nitrogen and glucose metabolism gene expression upon acute liver damage in mouse.

Authors:  Shahrouz Ghafoory; Katja Breitkopf-Heinlein; Qi Li; Catharina Scholl; Steven Dooley; Stefan Wölfl
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

7.  Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice.

Authors:  Sarah Alsamman; Stephanie A Christenson; Amy Yu; Nadia M E Ayad; Meghan S Mooring; Joe M Segal; Jimmy Kuang-Hsien Hu; Johanna R Schaub; Steve S Ho; Vikram Rao; Megan M Marlow; Scott M Turner; Mai Sedki; Lorena Pantano; Sarani Ghoshal; Diego Dos Santos Ferreira; Hsiao-Yen Ma; Caroline C Duwaerts; Regina Espanol-Suner; Lan Wei; Benjamin Newcomb; Izolda Mileva; Daniel Canals; Yusuf A Hannun; Raymond T Chung; Aras N Mattis; Bryan C Fuchs; Andrew M Tager; Dean Yimlamai; Valerie M Weaver; Alan C Mullen; Dean Sheppard; Jennifer Y Chen
Journal:  Sci Transl Med       Date:  2020-08-19       Impact factor: 19.319

8.  Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism.

Authors:  Wenjuan Liao; Hongbing Liu; Yiwei Zhang; Ji Hoon Jung; Jiaxiang Chen; Xiaohua Su; Yeong C Kim; Elsa R Flores; San Ming Wang; Malwina Czarny-Ratajczak; Wen Li; Shelya X Zeng; Hua Lu
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.996

Review 9.  Ceramide and Sphingosine 1-Phosphate in Liver Diseases.

Authors:  Woo-Jae Park; Jae-Hwi Song; Goon-Tae Kim; Tae-Sik Park
Journal:  Mol Cells       Date:  2020-05-31       Impact factor: 5.034

Review 10.  An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease.

Authors:  Ke Pei; Ting Gui; Dongfang Kan; Huichao Feng; Yanqiang Jin; Ying Yang; Qian Zhang; Ziwei Du; Zhibo Gai; Jibiao Wu; Yunlun Li
Journal:  Biomed Res Int       Date:  2020-07-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.